![Adjuvant Chemo for Colon Cancer Should Be Initiated Within 8 Weeks of Surgery - Cancer Therapy Advisor Adjuvant Chemo for Colon Cancer Should Be Initiated Within 8 Weeks of Surgery - Cancer Therapy Advisor](https://www.cancertherapyadvisor.com/wp-content/uploads/sites/12/2018/12/chemotherapycoloncancertrea_833288.jpg)
Adjuvant Chemo for Colon Cancer Should Be Initiated Within 8 Weeks of Surgery - Cancer Therapy Advisor
![ASCO on X: "Now available: New recommendations on adjuvant therapy for stage II #coloncancer ➡️ https://t.co/sWOrUcHSCV #crcsm https://t.co/Ne3ejiWx19" / X ASCO on X: "Now available: New recommendations on adjuvant therapy for stage II #coloncancer ➡️ https://t.co/sWOrUcHSCV #crcsm https://t.co/Ne3ejiWx19" / X](https://pbs.twimg.com/media/FHPZnE5XoAohoV_.jpg)
ASCO on X: "Now available: New recommendations on adjuvant therapy for stage II #coloncancer ➡️ https://t.co/sWOrUcHSCV #crcsm https://t.co/Ne3ejiWx19" / X
![Kaplan-Meier survival analysis for stage III colon cancer patients with... | Download Scientific Diagram Kaplan-Meier survival analysis for stage III colon cancer patients with... | Download Scientific Diagram](https://www.researchgate.net/publication/5534818/figure/fig1/AS:601727300550663@1520474376275/Kaplan-Meier-survival-analysis-for-stage-III-colon-cancer-patients-with-or-without.png)
Kaplan-Meier survival analysis for stage III colon cancer patients with... | Download Scientific Diagram
![3 versus 6 months of adjuvant oxaliplatin-fluoropyrimidine combination therapy for colorectal cancer (SCOT): an international, randomised, phase 3, non-inferiority trial - The Lancet Oncology 3 versus 6 months of adjuvant oxaliplatin-fluoropyrimidine combination therapy for colorectal cancer (SCOT): an international, randomised, phase 3, non-inferiority trial - The Lancet Oncology](https://www.thelancet.com/cms/attachment/2119314498/2092057955/gr1.gif)
3 versus 6 months of adjuvant oxaliplatin-fluoropyrimidine combination therapy for colorectal cancer (SCOT): an international, randomised, phase 3, non-inferiority trial - The Lancet Oncology
![Effect of duration of adjuvant chemotherapy for patients with stage III colon cancer (IDEA collaboration): final results from a prospective, pooled analysis of six randomised, phase 3 trials - The Lancet Oncology Effect of duration of adjuvant chemotherapy for patients with stage III colon cancer (IDEA collaboration): final results from a prospective, pooled analysis of six randomised, phase 3 trials - The Lancet Oncology](https://www.thelancet.com/cms/asset/c3854be2-2dc4-485e-80d5-acd23e1c3b90/gr1.jpg)
Effect of duration of adjuvant chemotherapy for patients with stage III colon cancer (IDEA collaboration): final results from a prospective, pooled analysis of six randomised, phase 3 trials - The Lancet Oncology
![Failure to complete adjuvant chemotherapy is associated with adverse survival in stage III colon cancer patients | British Journal of Cancer Failure to complete adjuvant chemotherapy is associated with adverse survival in stage III colon cancer patients | British Journal of Cancer](https://media.springernature.com/lw685/springer-static/image/art%3A10.1038%2Fsj.bjc.6603627/MediaObjects/41416_2007_Article_BF6603627_Fig2_HTML.jpg)
Failure to complete adjuvant chemotherapy is associated with adverse survival in stage III colon cancer patients | British Journal of Cancer
![Effect of adjuvant chemotherapy on survival benefit in stage III colon cancer patients stratified by age: a Japanese real-world cohort study | BMC Cancer | Full Text Effect of adjuvant chemotherapy on survival benefit in stage III colon cancer patients stratified by age: a Japanese real-world cohort study | BMC Cancer | Full Text](https://media.springernature.com/lw685/springer-static/image/art%3A10.1186%2Fs12885-019-6508-1/MediaObjects/12885_2019_6508_Fig2_HTML.png)
Effect of adjuvant chemotherapy on survival benefit in stage III colon cancer patients stratified by age: a Japanese real-world cohort study | BMC Cancer | Full Text
![Inferior oncological prognosis of surgery without oral chemotherapy for stage III colon cancer in clinical settings | World Journal of Surgical Oncology | Full Text Inferior oncological prognosis of surgery without oral chemotherapy for stage III colon cancer in clinical settings | World Journal of Surgical Oncology | Full Text](https://media.springernature.com/lw685/springer-static/image/art%3A10.1186%2F1477-7819-12-145/MediaObjects/12957_2014_Article_1631_Fig1_HTML.jpg)